These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 11358838)
1. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Shi Q; Le X; Abbruzzese JL; Peng Z; Qian CN; Tang H; Xiong Q; Wang B; Li XC; Xie K Cancer Res; 2001 May; 61(10):4143-54. PubMed ID: 11358838 [TBL] [Abstract][Full Text] [Related]
2. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Pal S; Datta K; Mukhopadhyay D Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575 [TBL] [Abstract][Full Text] [Related]
3. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Finkenzeller G; Sparacio A; Technau A; Marmé D; Siemeister G Oncogene; 1997 Aug; 15(6):669-76. PubMed ID: 9264407 [TBL] [Abstract][Full Text] [Related]
4. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Abdelrahim M; Smith R; Burghardt R; Safe S Cancer Res; 2004 Sep; 64(18):6740-9. PubMed ID: 15374992 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726 [TBL] [Abstract][Full Text] [Related]
6. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
8. Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells. Akiyama H; Tanaka T; Maeno T; Kanai H; Kimura Y; Kishi S; Kurabayashi M Invest Ophthalmol Vis Sci; 2002 May; 43(5):1367-74. PubMed ID: 11980848 [TBL] [Abstract][Full Text] [Related]
9. Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities. Ishibashi H; Nakagawa K; Onimaru M; Castellanous EJ; Kaneda Y; Nakashima Y; Shirasuna K; Sueishi K Cancer Res; 2000 Nov; 60(22):6531-6. PubMed ID: 11103824 [TBL] [Abstract][Full Text] [Related]
11. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035 [TBL] [Abstract][Full Text] [Related]
12. Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Brenneisen P; Blaudschun R; Gille J; Schneider L; Hinrichs R; Wlaschek M; Eming S; Scharffetter-Kochanek K Biochem J; 2003 Jan; 369(Pt 2):341-9. PubMed ID: 12358602 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Itakura J; Ishiwata T; Friess H; Fujii H; Matsumoto Y; Büchler MW; Korc M Clin Cancer Res; 1997 Aug; 3(8):1309-16. PubMed ID: 9815813 [TBL] [Abstract][Full Text] [Related]
15. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736 [TBL] [Abstract][Full Text] [Related]
16. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction. Masui T; Hosotani R; Doi R; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Tulachan SS; Imamura M Anticancer Res; 2002; 22(6C):4093-100. PubMed ID: 12553038 [TBL] [Abstract][Full Text] [Related]
17. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein. Lou Z; Maher VM; McCormick JJ Gene; 2005 May; 351():51-9. PubMed ID: 15857802 [TBL] [Abstract][Full Text] [Related]
18. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. Iervolino A; Trisciuoglio D; Ribatti D; Candiloro A; Biroccio A; Zupi G; Del Bufalo D FASEB J; 2002 Sep; 16(11):1453-5. PubMed ID: 12205045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]